Overview
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)
Description
A Multi-center, Open, Long-term Follow-up Study to Evaluate the Efficacy and Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid arthritis: 5-year Results From the K0202 Extension Study
Eligibility
Inclusion Criteria:
- Subject who enrolled K0202 Clinical Trial(parent study) and has been given more than one medication.
- Subjects who understand and voluntarily sign an informed consent form
Exclusion Criteria:
- Any other condition which the investigator judges would make patient unsuitable for study participation
